The unwanted results of the long-term treatment with Aβ(1–6)A2VTAT (D) might be determined by the TAT intrinsic ability to induce an increase in Aβ production, phosphorylation of tau and then neuronal death during AD development [52]. Here, MAPT is linked to Alzheimer disease.